Dr. Mary Mccormack

About Dr. Mary Mccormack

Dr. Mary McCormack’s is Experienced Clinical Oncologist specializing in gynaecological and breast cancers, including womb, cervix, uterus, ovary, vagina, and vulva.
Her Sub-specialist interests in cervical cancer treatments and targeted therapies for breast, endometrial, and ovarian cancers.
She Provides treatments including chemotherapy, radiotherapy, targeted/biological therapy, and brachytherapy.
She completed her Medical degree from Guy’s and St Thomas’ Hospital; PhD in Radiation Biology (1989); FRCR Clinical Oncology (2000).
She is a Consultant at University College London Hospitals (UCLH) since 2002.
Dr. Mary McCormack is a Chair of the Cervical Cancer Research Network (CCRN) and executive member of the Gynaecologic Cancer Intergroup (GCIG).
She is also Member of IGCS Education Committee and ASCO International Affairs Committee.
Dr. Mary Chief Investigator in numerous national and international clinical trials.
She has Authored multiple peer-reviewed publications and active in clinical education and research presentations.

Conditions treated by Dr. Mary Mccormack

Brachytherapy
Cervical Cancer
Breast Cancer
Gynaecological Cancers
uterine cancer
vaginal and vulval cancer
Ovary cancer
Chemotherapy
Biological therapy
Radiotherapy

Area of Interest

Clinical Oncology
Medical Oncology

Qualification

MBBS: Graduated from Guy’s and St Thomas’s Hospital, London, in 1993
PhD in Radiation Biology: Awarded in 1989
FRCR (Clinical Oncology): Achieved in 2000

Work Experiences

Consultant Clinical Oncologist at University College London Hospitals (UCLH): Appointed in 2002
Senior Clinical Oncologist for Gynaecological Cancer at UCLH: Leads referrals across the North London Cancer Network

Global Team of Board Certified Surgeons and Medical Specialists
Written Second Opinion report delivered within 5 days
Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Mary Mccormack on our platform

Consult Online

CERTIFICATIONS (1)

Fellow of the Royal College of Radiologists

MEMBERSHIPS (6)

Member of the General Medical Council
Chair: Cervical Cancer Research Network (CCRN).
Executive Member: Gynaecological Cancer Intergroup (GCIG).
Member: International Gynaecological Cancer Society (IGCS) Education Committee.
Member: American Society of Clinical Oncology (ASCO) International Affairs Committee.
Member: National Cancer Research Institute (NCRI) Gynaecological Cancer Clinical Studies Group.

RESEARCH PAPERS AND PUBLICATIONS (7)

McCormack M; Radiotherapy and Pregnancy 2008 in Cancer and Reproductive Health edited by Kehoe et al
Olaitan A, McCormack M; Centralisation of services for the management of ovarian cancer: arguments for, British Journal Obstetrics and Gyunaecology 2007; 114: 1188-1190.
Yu CK, Chiu C, McCormak M, Olaitan A Delayed Diagnosis of Cervical Cancer in Young Women, Journal of Obstetrics and Gynaecology 2005: 25: 367-370.
McCormack M, Brown RSD, Payne HA, The principles of radiotherapy In the Scientific Basis of Urology, 2nd edition, Mundy AR ed, Oxford, ISIS Medical Media 2002.
Thomas H, McCormack M, Mucins as markers in breast cancer. Tumour marker update 19987; 107-9
McCormack M, Nias AHW, Smith E Chronic Anaemia, Hyperbaric Oxygen and tumour Radisensitivity, British Journal of Radiology 1990;;63:752-759
McCormack M Anaemia Hyperbaric Oxygen and The Radiotherapy of tumours, PhD thesis. University of London January 1989.

Share Your Experience about Dr. Mary Mccormack

Write Your Review

PROCEDURES

Brachytherapy
Breast Cancer Treatment
Cervical Cancer Treatment
Chemotherapy
Intensity-modulated radiotherapy (IMRT)
Ovarian Cancer Treatment
Stereotactic Radio Therapy (SRT)
Uterine Cancer Treatment
Vaginal Cancer Treatment
Vulvar Cancer Treatment

FREQUENTLY ASKED QUESTIONS

Is Dr. Mary Mccormack doing teleconsultation on the MediGence platform?

Dr. Mary Mccormack is available to teleconsult on the MediGence platform.

How long is the consultation?

The consultation typically lasts between 15 and 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.

How soon can the consultation be organised?

We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.

Is a follow-up consultation included in the consultation price?

No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

How do I share my medical record with the doctor for review?

The option to share your medical records is available between the steps of the form provided to you on the website.

Can I schedule my procedure with the doctor after the consultation?

Yes. If you are satisfied with the consultation, you can proceed with treatment packages tailored to your diagnosis, assisted by our case managers.

Can you get an estimate for the procedure?

Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about travelling to your medical destination.

FAQ's Related to Medical Oncologist

What types of cancers are treated?

Specializes in gynaecological cancers (cervix, ovary, uterus, womb, vagina, vulva) and breast cancer, including all subtypes.

What treatments are provided?

Offers chemotherapy, radiotherapy, targeted/biological therapy, and brachytherapy.

Is there a focus on cervical cancer?

Yes, there is a sub-specialist focus on cervical cancer treatments and participation in clinical trials for optimized therapy protocols.

Are both early-stage and advanced cancers managed?

Yes, care is provided for both early-stage and advanced gynaecological and breast cancers with personalized treatment plans.

Is clinical research part of the practice?

Yes, the doctor leads multiple national and international clinical trials aimed at improving cancer treatments.

Is there involvement in medical education and guidelines?

Yes, actively contributes to clinical education and guideline development through international oncology committees and networks.

Welcome To MediGence

Your Notifications